New Resource
Practice Areas
Bar Admissions
- District of Columbia
- Maryland
- Massachusetts
- Washington, D.C.
-
1111 Pennsylvania Ave., NW
Washington, DC 20004-2541
Phone: 202.739.5458
Fax: 202.739.3001
55 Publications Found
| Date | Title | Publication |
| 10/29/09 |
False Claims Act Enforcement for the Health Industry—The FERA Game Changer for Compliance and Enforcement, presented at AHLA's False Claims Act Enforcement for the Health Industry Teleconference |
Speech |
| 10/26/09 |
Understanding Industry Guidance(s), presented at Seton Hall's Healthcare Compliance Certification Program, New Brunswick, NJ |
Speech |
| 10/13/09 |
Beyond FDA Enforcement Against FDA Regulated companies: Other Enforcement Concerns, presented at FDLI's Enforcement and Litigation Conference: Enforcement in a Post-Wyeth, New Administration World, Washington, D.C. |
Speech |
| 10/03/09 |
Breach of Notification and Reporting, presented at the 81st AHIMA Annual Convention and Exhibit, Grapevine, TX |
Speech |
| 07/14/09 |
Important Amendments Under the Fraud Enforcement & Recovery Act of 2009, presented as an ALI-ABA Webcast |
Speech |
| 07/09/09 |
Department of Justice and Sports Medicine: Are We Immune?, presented at the AOSSM: 2009 Annual Meeting, Keystone, CO |
Speech |
| 06/25/09 |
The Fraud Enforcement and Recovery Act of 2009: A New Day has Dawned for the False Claims Act Webinar
View Presentation
|
Webinar |
| 06/23/09 |
Supreme Court to Resolve the Scope of the FCA’s Jurisdictional “Public Disclosure Bar”
View LawFlash
|
Litigation LawFlash |
| 06/17/09 |
False Claims Act Amendments and New Anti-Fraud Provisions: Important Changes to Know About, presented an American Health Lawyers Association Webcast |
Speech |
| 06/10/09 |
Understanding Industry Guidance(s), presented at the Seton Hall Health Care Compliance Certification Program, Newark, NJ |
Speech |
| 05/27/09 |
Medical Device Counterfeiting: IP, Regulatory and Compliance Implications, presented at the AdvaMed 2009 International Medical Device Industry Compliance, Regulatory and IP Conference, Rome, Italy |
Speech |
| 05/09/09 |
Compliance: Focus on Drug Enforcement Agency (DEA) Issues in Long-Term Care, presented at the American Society of Consultant Pharmacists Midyear Educational Session, Orlando, FL |
Speech |
| 05/07/09 |
Remediation, Special Monitors, and Settling with the Government, presented at the National Institute on Internal Corporate Investigations and In-House Counsel 2009, Washington, D.C. |
Speech |
| 04/29/09 |
Compliance and Enforcement Update, presented at the 2009 AAOS National Orthopaedic Leadership Conference, Washington, D.C. |
Speech |
| 03/24/09 |
Lessons of Eli Lilly’s $1.4 Billion Off Label Zyprexa Settlement, presented at the National Pharma Audioconference |
Speech |
| 03/05/09 |
AKS and Industry Guidance, presented at the Seton Hall Health Care Compliance Certification Program, Newark, NJ |
Speech |
| 03/05/09 |
Multi-Jurisdictional Qui Tam Practice, presented at the ABA 23rd Annual National Institute on White Collar Crime, San Francisco |
Speech |
| 02/27/09 |
Developments in the Evolving Orthopaedic Surgeon: Industry Relationship, presented at the AAOS 2009 Annual Meeting Instructional Course and Symposium, Las Vegas, NV |
Speech |
| 01/22/09 |
Industry, Hospital and Physician Codes of Ethic and Financial Conflict of Interest Policies—How to Navigate Collaborations in a New and Evolving Compliance Era, presented at the AHLA Teleconference |
Speech |
| 2008 |
Stark Marches On: The 2009 IPPS Final Rule (co-author), a Member Briefing published by the American Health Lawyers Association's Fraud and Abuse Practice Group |
Article |
| 2007 |
Pharmaceutical Law: Regulation of Research, Development, and Marketing (co-author), Chapter 8: Federal Sentencing Guidelines and Compliance Measures, BNA and ABA Health Law Section |
Article |
| June 2004 |
Compliance Perspectives: Laboratory Compliance Hot Button Issues, Washington G2 Compliance Reports |
Article |
| January 2004 |
Physicians, Institutions and Pharma Relationships, APA Matrix |
Article |
| August 2003 |
OIG and Industry Pharma Guidance: How it Changes Compliance Advice, American Health Lawyers |
Article |
| April 2002 |
TAP Pharmaceuticals: “Mercy, Mercy, Me – Things Ain’t What They Used To Be…” American Health Lawyers |
Article |